Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories independent Auditor (Ernst & Young LLP) Total Fees ($M) ($M)
Form DEF 14A Proxy Statements (FY2018–FY2025)
Latest, FY2025
22,588,795
Period ended Dec 31, 2025
Change on a year earlier
+25,098,561.1%
90 in FY2024
History
8 years
Since FY2018
Sources
7
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Independent Auditor (Ernst & Young LLP) Total Fees ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 22,588,795 | +25,098,561.1% | SEC Filing (0001308179-26-000064) ↗ |
| FY2024 | Dec 31, 2024 | 90 | -100.0% | SEC Filing (0001308179-26-000064) ↗ |
| FY2023 | Dec 31, 2023 | 36,088,000 | +6.2% | SEC Filing (0001308179-25-000134) ↗ |
| FY2022 | Dec 31, 2022 | 33,969,000 | +4.1% | SEC Filing (0001308179-24-000182) ↗ |
| FY2021 | Dec 31, 2021 | 32,631,000 | +3.0% | SEC Filing (0001308179-23-000247) ↗ |
| FY2020 | Dec 31, 2020 | 31,675,000 | -0.4% | SEC Filing (0001206774-22-000778) ↗ |
| FY2019 | Dec 31, 2019 | 31,806,000 | -9.3% | SEC Filing (0001047469-21-000592) ↗ |
| FY2018 | Dec 31, 2018 | 35,064,000 | – | SEC Filing (0001047469-20-001466) ↗ |
Breakdown
What makes up independent auditor (ernst & young llp) total fees ($m)
Cite this data
StockData. (2026). Abbott Laboratories Independent Auditor (Ernst & Young LLP) Total Fees ($M) ($M), annual FY2018–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/audit-tot-fees
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.